| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/11/2010 | WO2010129445A2 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |
| 11/11/2010 | WO2010129337A2 New oral formulations for tetrapyrrole derivatives |
| 11/11/2010 | WO2010129309A2 Microencapsulated compositions and methods for tissue mineralization |
| 11/11/2010 | WO2010129184A2 Magnetic particles for delivering therapeutic agent to a target location |
| 11/11/2010 | WO2010129067A1 Improved methylidene malonate process |
| 11/11/2010 | WO2010128949A1 A nutraceutical composition |
| 11/11/2010 | WO2010128889A1 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles |
| 11/11/2010 | WO2010128504A2 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery |
| 11/11/2010 | WO2010128486A2 Ophthalmic formulation for the treatment and prevention of pterygium |
| 11/11/2010 | WO2010128300A1 Composition for sustained drug delivery comprising geopolymeric binder |
| 11/11/2010 | WO2010128111A1 Concentrated mast cell stabilizing pharmaceutical formulations |
| 11/11/2010 | WO2010128004A1 Intrauterine system for use in medical treatment |
| 11/11/2010 | WO2010127674A1 Transdermal compositions of asenapine for the treatment of psychiatric disorders |
| 11/11/2010 | WO2010127647A1 Compositions for wound treatment in the human and veterinary field |
| 11/11/2010 | WO2010127541A1 A nano-emulsion injection of vinca alkaloids and the preparation method thereof |
| 11/11/2010 | WO2010127470A1 Paeoniflorin preparations and uses thereof for fat reduction |
| 11/11/2010 | WO2010107342A3 Agent and method for washing down solid dosage forms |
| 11/11/2010 | WO2010091649A3 A composition for buccal absorption of nicotine for the purpose of smoking cessation |
| 11/11/2010 | WO2010086129A8 Inclusion complex comprising cinacalcet and cyclodextrin |
| 11/11/2010 | WO2010079978A3 Composition for improving inflammatory disease using abh antigens |
| 11/11/2010 | WO2010074540A3 Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 11/11/2010 | WO2010004299A3 Pharmaceutical compositions of somatotrophic hormones |
| 11/11/2010 | WO2009092516A3 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 11/11/2010 | WO2009086483A3 Biocompatible protein particles, devices and methods thereof |
| 11/11/2010 | WO2008148080A8 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin] |
| 11/11/2010 | WO2004062646A9 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 11/11/2010 | US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 11/11/2010 | US20100286793 Device for minimally invasive plastic surgery lift procedure |
| 11/11/2010 | US20100286762 Compositions and Methods for Ameliorating Clinical Electrical Disturbances |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286066 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100285158 Effervescent composition including cranberry extract |
| 11/11/2010 | US20100285144 Polymer-epothilone conjugates, particles, compositions, and related methods of use |
| 11/11/2010 | US20100285143 Orally administerable solid pharmaceutical composition and a process thereof |
| 11/11/2010 | US20100285142 Method Of Making Particles For Use In A Pharmaceutical Composition |
| 11/11/2010 | US20100285141 Compositions and methods for enhancing the activity of podophyllotoxin |
| 11/11/2010 | US20100285140 Antimicrobial agent for gram-positive bacteria |
| 11/11/2010 | US20100285139 Pharmaceutical composition for the prophylaxis and/or symptomatic treatment of cystic fibrosis |
| 11/11/2010 | US20100285138 Compositions comprising nanoparticles and apoptotic agents and methods of use |
| 11/11/2010 | US20100285137 Antibiotic/bone morphogenic protein formulation and method of treatment |
| 11/11/2010 | US20100285135 Nanoparticles For Use In Immunogenic Compositions |
| 11/11/2010 | US20100285134 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 11/11/2010 | US20100285133 Transdermal drug delivery system containing granisetron |
| 11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
| 11/11/2010 | US20100285131 Fgf21 mutants and uses thereof |
| 11/11/2010 | US20100285130 Coating of complexed actives in film formulations |
| 11/11/2010 | US20100285128 Space filled drug release structure and method of manufacturing the same |
| 11/11/2010 | US20100285127 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives |
| 11/11/2010 | US20100285126 Pharmaceutical compositions of fenofibrate |
| 11/11/2010 | US20100285125 Delivery system for poorly soluble drugs |
| 11/11/2010 | US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological |
| 11/11/2010 | US20100285123 Controlled Release Dosage Formulation of Duloxetine |
| 11/11/2010 | US20100285122 Tablets for combination therapy |
| 11/11/2010 | US20100285121 Capsule Formulation |
| 11/11/2010 | US20100285120 Controlled release preparation |
| 11/11/2010 | US20100285119 Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same |
| 11/11/2010 | US20100285118 Encapsulated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating |
| 11/11/2010 | US20100285117 Combination of triazine derivatives and insulin sensitisers |
| 11/11/2010 | US20100285116 Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells |
| 11/11/2010 | US20100285115 Novel Antiretroviral Combination |
| 11/11/2010 | US20100285114 Pharmaceutical compositions of rhein or diacerein |
| 11/11/2010 | US20100285113 Enhanced stability of inverse thermal gelling composite hydrogels |
| 11/11/2010 | US20100285112 Methods of delivering oligonucleotides to immune cells |
| 11/11/2010 | US20100285111 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 11/11/2010 | US20100285110 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285108 Method for therapeutic use |
| 11/11/2010 | US20100285107 Short nucleic acid molecule-mediated modulation of aurora b kinase expression and combinations for use in anticancer therapy |
| 11/11/2010 | US20100285106 Multicomponent vaccine |
| 11/11/2010 | US20100285105 Oil producing microbes adn method of modification thereof |
| 11/11/2010 | US20100285104 Compositions and methods for the delivery of oxygen |
| 11/11/2010 | US20100285103 Medicament for treatment of tumors and the use thereof |
| 11/11/2010 | US20100285102 Colloidal collagen burn wound dressing produced from jellyfish |
| 11/11/2010 | US20100285101 Composite nonwoven fibrous webs and methods of making and using the same |
| 11/11/2010 | US20100285099 Vaccination by transcutaneous targeting |
| 11/11/2010 | US20100285098 Adhering troches with santacid for treatment of throat esophagus and stomach |
| 11/11/2010 | US20100285094 Polymeric compositions and methods of making and using thereof |
| 11/11/2010 | US20100285087 Single phenothiazine enantiomers as agents for the prevention of bone loss |
| 11/11/2010 | US20100285083 Drug delivery system |
| 11/11/2010 | US20100285082 Integrated Biosensor and Simulation System for Diagnosis and Therapy |
| 11/11/2010 | US20100285077 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid |
| 11/11/2010 | US20100285075 Novel Hemioxalate Salt of Eletriptan |
| 11/11/2010 | US20100285074 Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100284983 Coenzyme q10-containing water-soluble composition and process for production thereof |
| 11/11/2010 | US20100284946 Compressed Chewing Gum Comprising Sterol |
| 11/11/2010 | US20100284945 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 11/11/2010 | US20100284944 Off-note blocking sensory organic compounds |
| 11/11/2010 | US20100284940 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 11/11/2010 | US20100284939 Hair care compositions and methods of treating hair using same |
| 11/11/2010 | US20100284938 Penetrating pharmaceutical foam |
| 11/11/2010 | US20100284937 Vaginal lubricant comprising hyaluronic acid |
| 11/11/2010 | US20100284924 Nano-devices having impellers for capture and release of molecules |
| 11/11/2010 | US20100284911 Preparations and methods for treating malignancies |
| 11/11/2010 | US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | US20100282247 Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin |
| 11/11/2010 | DE102009019491A1 Device for applying medicinal preparation in the form of powdered lyophilizate to eyes of patients, comprises an applicator with holder for receiving a container, an adapter communicating with holder, and a compressed air-source |
| 11/11/2010 | CA2761042A1 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery |
| 11/11/2010 | CA2761000A1 Composition for sustained drug delivery comprising geopolymeric binder |